Biotech

All Articles

Galapagos stops CAR-T tissue treatment litigation over Parkinsonism situation

.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T cell therapy...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After much more than three decades, genetics therapy trendsetter James Wilson M.D., Ph.D., is leavi...

3 biotechs make an effort to trump the summer warmth by shedding team

.As biotechs try to switch a new webpage in August, a minimum of three providers have actually lost ...

venBio elevates $528M for fifth life sciences VC fund

.Pro equity capital company venBio has actually elevated another half a billion bucks to purchase bi...

Otsuka spends $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Pharmaceutical has actually gotten Boston-based Jnana Therapeutics for $800 million so the E...

FibroGen gives up 75% of US team as resource fails 2 additional tests

.FibroGen is significantly restructuring its own organization, giving up 75% of its own USA team and...

Tracon unwind weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has actually determined to wind down functions full weeks after an injectabl...

Ideaya bags choice on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on failed epilepsy medication, touts FDA run

.Our team already recognize that Takeda is wishing to find a pathway to the FDA for epilepsy medicat...

VBI Vaccines declare bankruptcy, finds resource sale

.Immunology biotech VBI Vaccinations is drifting hazardously near to the point of no return, along w...